How and why the drug industry uses economic evaluations Newsletter Article 08 February 2013 Pages: 2 - 2
Managed care needs disease management models for depression Newsletter Article 08 February 2013 Pages: 4 - 4
Epirubicin favoured over doxorubicin in breast cancer Newsletter Article 08 February 2013 Pages: 5 - 5
Quality focus teams decrease cost of serotonin antagonists Newsletter Article 08 February 2013 Pages: 5 - 5
Change antihypertensive drug class, increase acquisition costs Newsletter Article 08 February 2013 Pages: 5 - 5
Abciximab use warranted in high-risk coronary angioplasty Newsletter Article 08 February 2013 Pages: 6 - 6
Vaccine cost effective in chronic bronchitis prevention Newsletter Article 08 February 2013 Pages: 6 - 6
Retrospective DUR reduces antiulcer prescribing costs Newsletter Article 08 February 2013 Pages: 6 - 6
Consider the costs of NSAID/antiulcer co-prescribing Newsletter Article 08 February 2013 Pages: 7 - 7